146 related articles for article (PubMed ID: 1449973)
1. Erythropoietin for anemia of cancer: higher hematocrits, fewer transfusions.
Oncology (Williston Park); 1992 Sep; 6(9):19. PubMed ID: 1449973
[No Abstract] [Full Text] [Related]
2. Erythropoietin therapy in cancer patients.
Doweiko JP; Goldberg MA
Oncology (Williston Park); 1991 Aug; 5(8):31-7; discussion 38, 43-4. PubMed ID: 1834151
[TBL] [Abstract][Full Text] [Related]
3. Cancer-related anemia: clinical review and management update.
Hurter B; Bush NJ
Clin J Oncol Nurs; 2007 Jun; 11(3):349-59. PubMed ID: 17623620
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin treatment of anemic cancer patients.
Henry DH
Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
[TBL] [Abstract][Full Text] [Related]
5. Anemia and quality of life in cancer patients: impact of transfusion and erythropoietin.
Thomas ML
Med Oncol; 1998 Aug; 15 Suppl 1():S13-8. PubMed ID: 9785332
[TBL] [Abstract][Full Text] [Related]
6. [Use of erythropoietin in the treatment of cancer-related anemia].
Huang JX; Meng FJ
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):877-8. PubMed ID: 22335959
[No Abstract] [Full Text] [Related]
7. [Erythropoietin--the first hematologic hormone in clinical use].
Rhyner K
Schweiz Med Wochenschr; 1988 Mar; 118(11):375-80. PubMed ID: 3287601
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin for anaemia in cancer patients.
Abels R
Eur J Cancer; 1993; 29A Suppl 2():S2-8. PubMed ID: 8398361
[No Abstract] [Full Text] [Related]
9. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer.
Abels RI
Semin Oncol; 1992 Jun; 19(3 Suppl 8):29-35. PubMed ID: 1615337
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin and renal anemia.
Hörl WH
Biotechnol Ther; 1991; 2(3-4):213-30. PubMed ID: 1845127
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
12. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
13. Can higher hematocrits prove of value for ESRD patients?
Nephrol News Issues; 1999 Sep; 13(9):30-1. PubMed ID: 10776250
[No Abstract] [Full Text] [Related]
14. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin].
Adam Z; Krejcí M; Vorlícek J
Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717
[TBL] [Abstract][Full Text] [Related]
15. [Autologous blood pre-donation and perioperative use of erythropoietin].
Michaeli B; Ravussin P; Chassot PG
Rev Med Suisse; 2006 Nov; 2(88):2662-4, 2666-7. PubMed ID: 17265804
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of recombinant erythropoietin in anemic cancer patients.
Henry DH
Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of anemia in patients with tumors].
Tesarová P; Kvasnicka J
Cas Lek Cesk; 1995 Oct; 134(20):647-50. PubMed ID: 7489579
[TBL] [Abstract][Full Text] [Related]
18. Changing patterns of care in the management of anemia.
Henry DH
Semin Oncol; 1992 Jun; 19(3 Suppl 8):3-7. PubMed ID: 1615338
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of anemia in patients on a regular dialysis program using human recombinant erythropoietin].
Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartůnková J; Válek A
Cas Lek Cesk; 1989 Sep; 128(40):1257-60. PubMed ID: 2582471
[TBL] [Abstract][Full Text] [Related]
20. Review of patients' responses to epoetin alfa therapy.
Krantz SB
Pharmacotherapy; 1990; 10(2 ( Pt 2)):15S-21S. PubMed ID: 2189124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]